Dr. Carmel Armon, MD

Dr. Armon practices at Riverside University Medical Center in Moreno Valley, California.

Dr. Armon's NPI, 1295835916, was assigned on September 23, 2006. Dr. Armon graduated from Technion-Israel Inst of Technology Faculty of Medicine in 1980. Dr. Armon holds California license A49306.

Dr. Armon's primary practice is Riverside University Medical Center, at 26520 Cactus Ave, Moreno Valley, CA 92555 in Riverside County. The practice phone is (951) 486-4458.

Dr. Armon's primary practice is Riverside University Medical Center in Moreno Valley, California. Dr. Armon is also affiliated with Riverside University Health System - Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Armon to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Armon practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Armon's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Armon is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Armon's licenses on file in 4 states: California, Massachusetts, Minnesota and North Carolina.

Dmand AI lists acute mini-stroke (TIA) and non-alzheimer's dementia (chronic) among the conditions Dr. Armon treats.

CMS data shows 86 Medicare services from Dr. Armon across 5 procedure codes in 2024, for 88 Medicare patients. Medicare paid $8,910 for them. Every service was in an office.

CMS counts 88 Medicare patients who saw Dr. Armon in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Armon's median patient age at 70, with 56% women.

In 2024, Dr. Armon wrote 135 Medicare Part D claims for 30 patients. 100% of them were for generic drugs. CMS names the drug for 90 of them, across 4 drugs with 11 or more claims each, at $1,230 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Armon for performance year 2024, reported as part of a group. Dr. Armon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Armon as offering telehealth.

Dmand AI links 78 papers to Dr. Armon, published from 2010 to 2024. 2022 was the busiest year, with 5. The most frequent topics are Amyotrophic Lateral Sclerosis, Israel and Neurology. Dr. Armon has published most often in Neurology. Dr. Armon's most frequent co-authors are Tulio E. Bertorini, MD, Richard Stanley Bedlack, MD, PhD and Robert Miller, MD.

CMS Open Payments shows 3 general payments to Dr. Armon from 3 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Eisai Inc. paid the most, $125.

Dr. Armon graduated from Technion-Israel Inst of Technology Faculty of Medicine in 1980. Dr. Armon is a member of AAN.

Dr. Armon is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.